Sirvent Elia, Ruiz Montserrat, Rodríguez Juan C, Royo Gloria
Servicio de Microbiología, Hospital General Universitario de Elche, Universidad Miguel Hernández, Alicante, España.
Enferm Infecc Microbiol Clin. 2006 Dec;24(10):603-7. doi: 10.1157/13095370.
The objective of this study was to compare the activity of ciprofloxacin, levofloxacin, moxifloxacin, gatifloxacin and ofloxacin against Pseudomonas aeruginosa by determining the mutant prevention concentration (MPC).
Thirty-four clinical isolates of Pseudomonas aeruginosa causing nosocomial infection were studied. MPC values were determined using an inoculum of 10(10) cfu/mL on Mueller-Hinton plates with serial dilutions of the antibiotics. The microorganisms were classified according to whether the patients had been previously treated with fluoroquinolones or not.
The fluoroquinolone with the lowest MPC values was ciprofloxacin, followed by levofloxacin. Analysis of strains from patients previously treated with fluoroquinolones showed persistent susceptibility according to the CLSI criteria, but with lower activity of all the drugs.
Although the microorganism remained susceptible to fluoroquinolones according to classical methods, the suitability of using these drugs in patients with severe infection and a history of fluoroquinolone use should be evaluated.
本研究的目的是通过测定突变预防浓度(MPC)来比较环丙沙星、左氧氟沙星、莫西沙星、加替沙星和氧氟沙星对铜绿假单胞菌的活性。
对34株引起医院感染的铜绿假单胞菌临床分离株进行了研究。在含有系列稀释抗生素的穆勒-欣顿平板上,使用10(10) cfu/mL的接种物测定MPC值。根据患者先前是否接受过氟喹诺酮类药物治疗对微生物进行分类。
MPC值最低的氟喹诺酮类药物是环丙沙星,其次是左氧氟沙星。对先前接受过氟喹诺酮类药物治疗的患者的菌株分析表明,根据CLSI标准,这些菌株仍具有敏感性,但所有药物的活性均较低。
尽管根据经典方法该微生物对氟喹诺酮类药物仍敏感,但对于有严重感染且有氟喹诺酮类药物使用史的患者,使用这些药物的适用性仍应进行评估。